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NUTRITIONAL STATUS AND BODY COMPOSITION IN PERITONEAL
DIALYSIS PATIENTS: RELEVANCE OF BIOIMPEDANCEMETRY (BCMs)
FOR LONGITUDINAL MONITORING
Celine Nodimar, Karine Moreau, Christian Combe, Philippe Chauveau
Nephrology Dialysis Unit, Pellegrin Hospital, Bordeaux, France
The protein-energy wasting is common in patients with renal failure
including patients on peritoneal dialysis (PD) and is closely linked to an
increased risk of morbi- mortality. The purpose of this study was to
evaluate the relevance of bioimpedance spectroscopy (BIS) to assess
longitudinal body composition (BC) modiﬁcations in incident and
prevalent peritoneal dialyzed patients.
49 patients (16 women - 33 men) between January and December 2010
were included in this longitudinal, prospective, multicentric study. 18 of
them (all men) were prevalent patients. Clinical (height, weight), biological
(albumin, prealbumin, nPCR) and BIS (BCMs, Fresenius Medical Care)
were collected at baseline, and months 3, 6 and 9. BC parameters are
expressed as lean tissue index (LTI kg/m2 for fat free mass/ height squared)
and fat tissue index index (FTI kg/m2 for fat mass/ height squared).
Comparisons of data over time were conducted in pairs between 0 and
9 months.
At baseline, albumin (34.176.1 g/L), prealbumin (0.3970.12 g/L) and
nPCR (0.9070.24 g/24h) met the nutritional recommendations for PD
patients. Mean weight was 71.7715.0 Kg. Mean LTI was 12.673.4 kg/m2
and FTI was 12.3 7 6.1 kg/m2. 37% of our population had an LTI below
the 10th percentile and 16% have an FTI above the 90th percentile. After
9 months, mean weight remained stable for the whole population. At
month 9, no change in the biological parameters was detected. LTI
decreased signiﬁcantly for all patients (-0.66870.2 kg/m2), with a
concomitant increase of FTI (1.0570.27 kg/m2). These changes were
greater in patients over 65 years, and faster in incident dialyzed patients.
These changes were not inﬂuenced by residual renal function nor by the
glucose exposition.
We conﬁrm that PD is associated with changes in BC, whether for
incident or prevalent patients. The BCMs, a simple, reproducible and
inexpensive technique, could be proposed in the systematic nutritional
monitoring of PD patients, in order to detect early modiﬁcation of
nutritional status in those patients and then to adapt clinical management.
http://dx.doi.org/10.1016/j.krcp.2012.04.633
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THE STUDY OF EFFECT OF KETOANALOGUES IN DELAYING PROGRESSION
OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH
DIABETIC NEPHROPATHY
L.H. Suratkal, Ashwini Khandekar
Bhabha Atomic Research Centre Hospital, Mumbai, India.
It has been proposed that protein-restricted diets may slow down the
rate of progression and change the prognosis of patients with progressive
CKD. The present study was conducted to assess the clinical efﬁcacy and
safety of low protein diet (LPD) supplemented with ketoanalogues (KA) in
the treatment of diabetic nephropathy (DN) in comparison with LPD alone.
Forty eight Diabetic Nephropathy patients at B.A.R.C. hospital, Mumbai
were selected for participation in the study and were randomized to
receive either LPD (0.6 g/kg BW/day) þ ketoanalogues or the control
treatment of LPD (0.6 g/kg BW/day). Both the groups received the
treatment for mean duration of 31 months and followed up for 5 years.
Renal functions, nutritional and metabolic status were assessed and
compared at periodic intervals and at the end of 5 years follow up. The
baseline characteristics, disease severity, renal dysfunction, metabolic
derangements and demographic parameters were matched in both the
groups. Serum creatinine was 2.44 and 2.32 mg/dL in study and control
groups respectively at baseline, GFR in study and control group was 33.42
and 40.13 mL/min/1.73 m2 respectively at baseline. Serum PTH levels at
baseline in study and control group was 125.14 and 100.97 pg/mL
respectively. At the end of 5 years, serum creatinine was 2.84 and 3.48 mg/
dL, GFR was 8.08 and 7.38 13 mL/min/1.73 m2 , serum PTH was 519.96
and 707.23 pg/mL in study and control groups respectively. Serum
phosphorous levels in study group and control group at baseline were 4.06
and 3.94 mg/dL respectively. At the end of 5 years these levels were 3.84
and 4.0 /dL respectively. The detail statistical analysis and other
observations will be presented. It has been observed that LPDþKA is
superior to LPD in delaying the progression of CKD towards the ESRD. It is
also superior to LPD in decreasing the serum phosphorus levels and thus
delaying the occurrence of secondary parahyperthyroidism and renal
osteodystrophy. In maintaining the nutritional status of the patients,
Glycemic control and blood pressure control, LPDþKA has played a role
superior to that of LPD.
http://dx.doi.org/10.1016/j.krcp.2012.04.634
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A RANDOMIZED CONTROLLED TRIAL OF DIETARY AND LIFESTYLE
MODIFICATION BASED ON THE EMPOWERMENT APPROACH AMONG
CHRONIC KIDNEY DISEASE PATIENTS
Yupa chanwikrai, Buncha satirapod
Dollapas Punpanich, Ouppatham supasyndh, Division of nephrology,
Phramongkutklao Hospital, Bangkok, Thailand
Changes of diet and lifestyle can slow the progression of chronic kidney
disease (CKD). We aimed to study the effect of dietary modiﬁcation with or
without exercise by the empowerment approach in CKD patients. The 12-
week protocol was conducted in patients with CKD stage 3-5. The
participants were randomly assigned to be a standard care (C) group, a
diet-managed (D) group or a diet plus exercise-managed (DE) group. All
groups were advised on low protein (0.6-0.8 g/kg/day) and low salt (5 g/
day) diet. Group D and DE participated in the empowerment activities
during the study. Blood and urine were collected for nutrition evaluation.
Eighty-one patients completed the study program (96%). At baseline, there
was not signiﬁcantly difference in characteristics among the three groups,
whereas, at the end of the study, there were signiﬁcantly decreased in
systolic (SBP) and diastolic BP (DBP), and normalize protein nitrogen
appearance (nPNA) in group D and DE, when compared with C. (Table)
We summarized that dietary and lifestyle modiﬁcation based on the
empowerment approach improved SBP, DBP and reduced dietary protein
intake, and it might help CKD patients reduce salt intake.
http://dx.doi.org/10.1016/j.krcp.2012.04.635
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THE CORRELATION OF SERUM PREALBUMIN AND ROUTINE NUTRITION
PARAMETERS IN CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS PATIENTS
Yupa Chanwikrai, Buncha Satirapod, Achara Boonyakarn
Dollapas Punpanich, Ouppatham supasyndh, Division of nephrology,
Phramongkutklao Hospital, Bangkok, Thailand
Prealbumin is evidenced to reﬂect recent dietary intake rather than
overall nutrition status because of its short half-life. Most of continuous
ambulatory peritoneal dialysis (CAPD) patients show hypoalbuminnemia.
However, there are many factors which may inﬂuence the level of albumin
in serum. We demonstrated the correlation of prealbumin and other
common nutritional markers in CAPD patients. All participants were
undergoing peritoneal dialysis more than 3 months with no active
infection elsewhere. The participants were asked to do the handgrip
strength (HGS) by Grip strength dynamometer (T.K.K.5001) and
bioelectrical impedance analysis. Serum prealbumin, albumin and
C-reactive protein (CRP) were tested. Of 48 patients, 56% had serum
albumin less than 3.5 g/dL (3.3970.43) while prealbumin more than
0.35 g/L (0.3570.08). Sixty-eight percent of all participants had HGS
Mean 7 SD at the end of study p
C (n ¼ 27) D (n ¼ 28) DE (n ¼ 26)
SBP, mmHg 138.94719.41 132.21719.04 125.19712.5 0.019*
DBP, mmHg 75.1479.06 66.578.55 70.31711.94 0.010*
BUN, mg/dL 26.670.28 28.5714.34 25.7716.04 0.791
SCr, mg/dL 1.9570.21 2.0770.85 2.0771.08 0.986
Salb, g/dL 4.1570.21 4.3170.44 4.470.32 0.541
nPNA,g/kg/d 0.9470.33 0.7470.28 0.7570.19 0.020*
UrineNa, mg/d 3298.4171578.6 2489.4771364.05 2873.3971008.19 0.09
n po0.05 vs. group C, Scr: serum creatinine, Salb: serum albumin,
UrinNa: urine sodium
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